Medical School · Year 3 · General Surgery · includes a quiz and discussion video

Seminar 17: Surgical Critical Care

General Surgery Clerkship - Unit 17

Learning Objectives

By the end of this seminar, students will be able to:

1. Classify shock states based on hemodynamic parameters and initiate appropriate resuscitative interventions
2. Apply evidence-based management strategies for sepsis and septic shock in surgical patients
3. Describe mechanical ventilation modes, initial settings, and lung-protective ventilation strategies
4. Recognize acute respiratory distress syndrome and implement management algorithms
5. Apply principles of nutritional support and metabolic management in critically ill surgical patients
6. Identify common ICU complications and implement prevention bundles to reduce morbidity

Seminar Outline

I. Shock: Definition, Recognition, and Classification

Shock represents a state of circulatory failure resulting in inadequate tissue perfusion and cellular oxygen delivery. At the cellular level, shock produces a shift from aerobic to anaerobic metabolism, leading to lactate accumulation, cellular dysfunction, and ultimately cell death. The fundamental pathophysiology involves an imbalance between oxygen delivery and oxygen consumption, where tissues cannot extract sufficient oxygen to meet metabolic demands. Early recognition remains paramount because the compensatory mechanisms that initially maintain vital organ perfusion eventually fail, leading to progressive organ dysfunction and death if not reversed.

The four major categories of shock are distinguished by their underlying hemodynamic profiles. Hypovolemic shock results from intravascular volume depletion due to hemorrhage, dehydration, or third-spacing, producing decreased cardiac output with compensatory increased systemic vascular resistance. Cardiogenic shock occurs when the heart fails as a pump, seen in myocardial infarction, severe arrhythmias, or valvular emergencies, also presenting with decreased output but elevated filling pressures. Distributive shock, most commonly septic shock, involves pathologic vasodilation with decreased systemic vascular resistance, initially producing a hyperdynamic state with increased cardiac output that later decompensates. Obstructive shock results from mechanical impediments to circulation such as tension pneumothorax, cardiac tamponade, or massive pulmonary embolism.

Clinical recognition of shock requires integration of multiple parameters beyond blood pressure alone. Hypotension, defined as mean arterial pressure less than 65 mmHg, is a late finding that indicates decompensation, while tachycardia represents an early compensatory response. Oliguria developing when urine output falls below 0.5 mL/kg/hour reflects renal hypoperfusion. Altered mental status ranging from confusion to obtundation indicates cerebral hypoperfusion. Mottled skin, particularly over the knees, and cool extremities with delayed capillary refill suggest peripheral vasoconstriction. Elevated serum lactate greater than 2 mmol/L provides biochemical evidence of tissue hypoxia and anaerobic metabolism.

Hemodynamic monitoring guides shock classification and management. Central venous pressure, normally 2-8 mmHg, reflects right heart preload and intravascular volume status. Cardiac output measurement through thermodilution or echocardiography quantifies pump function. Systemic vascular resistance calculations help distinguish vasodilated from vasoconstricted states. Mixed venous oxygen saturation (SvO2) or central venous oxygen saturation (ScvO2) greater than 70% suggests adequate oxygen delivery relative to consumption. Point-of-care ultrasound has revolutionized bedside assessment, allowing rapid evaluation of cardiac function, volume status, and identification of correctable causes like tamponade or pneumothorax.

<image>Panel A: Diagram showing the four types of shock (hypovolemic, cardiogenic, distributive, obstructive) with representative hemodynamic profiles showing arrows for cardiac output, SVR, and CVP. Panel B: Clinical assessment findings in shock including mottled skin over knees, delayed capillary refill test, and signs of end-organ hypoperfusion. Panel C: Hemodynamic monitoring parameters displayed on bedside monitor showing CVP waveform, arterial line tracing, and cardiac output values. Panel D: Point-of-care ultrasound images showing IVC assessment for volume status and parasternal cardiac views.</image>

II. Shock Management Principles

Management of hypovolemic shock focuses on source control and volume restoration. In hemorrhagic shock, the priority is identifying and controlling the bleeding source through direct pressure, tourniquet application for extremity hemorrhage, or emergent surgical intervention. Intravenous access should include two large-bore peripheral catheters or central venous access. Initial resuscitation uses crystalloid fluids, though massive hemorrhage requires early balanced blood product transfusion with a 1:1:1 ratio of packed red blood cells, fresh frozen plasma, and platelets. Non-hemorrhagic hypovolemic shock from dehydration or third-spacing responds to crystalloid resuscitation with monitoring of urine output and lactate clearance as endpoints.

Cardiogenic shock management requires identifying and treating the underlying cause while supporting cardiac function. Acute myocardial infarction causing cardiogenic shock warrants emergent revascularization through percutaneous coronary intervention or coronary artery bypass grafting. Fluid administration must be cautious as excessive volume worsens pulmonary congestion without improving forward flow. Inotropic support with dobutamine or milrinone increases contractility, while norepinephrine may be needed if hypotension persists despite inotropes. Mechanical circulatory support options include intra-aortic balloon pump counterpulsation, Impella percutaneous ventricular assist devices, or extracorporeal membrane oxygenation for refractory cases.

Distributive shock, most commonly septic shock, requires aggressive fluid resuscitation and early vasopressor therapy. Initial crystalloid boluses of 30 mL/kg are administered within the first three hours for patients with hypotension or lactate greater than 4 mmol/L. Norepinephrine is the first-line vasopressor, targeting mean arterial pressure of 65 mmHg. If norepinephrine doses exceed 0.5 mcg/kg/min, vasopressin is added as a second agent. Epinephrine or dobutamine may be added for patients with cardiac dysfunction. Source control through surgical drainage or debridement must occur within 6-12 hours of sepsis recognition. Neurogenic shock from spinal cord injury presents with bradycardia and hypotension requiring fluids and vasopressors.

Obstructive shock demands immediate intervention to relieve the mechanical obstruction. Tension pneumothorax requires needle decompression in the second intercostal space at the midclavicular line followed by tube thoracostomy. Cardiac tamponade is treated with emergent pericardiocentesis or surgical pericardial window. Massive pulmonary embolism with hemodynamic instability warrants consideration of systemic thrombolysis, catheter-directed therapy, or surgical embolectomy. Recognition relies on maintaining high clinical suspicion, as obstructive shock can rapidly progress to cardiac arrest. Bedside ultrasound provides rapid diagnosis showing pneumothorax (absent lung sliding), tamponade (pericardial effusion with right ventricular collapse), or right heart strain suggesting pulmonary embolism.

<image>Panel A: Algorithm flowchart for hypovolemic shock management showing decision points for hemorrhagic versus non-hemorrhagic causes and resuscitation strategies including massive transfusion protocol activation. Panel B: Cardiogenic shock management showing inotrope and vasopressor selection with mechanical support device options (IABP, Impella, ECMO). Panel C: Septic shock resuscitation bundle with crystalloid administration, vasopressor titration, and source control timeline. Panel D: Obstructive shock interventions including needle decompression technique for tension pneumothorax and pericardiocentesis approach.</image>

III. Sepsis and Septic Shock

Sepsis, as defined by the Sepsis-3 consensus criteria, represents life-threatening organ dysfunction caused by dysregulated host response to infection. The clinical identification relies on the Sequential Organ Failure Assessment (SOFA) score, where sepsis is diagnosed when infection produces an acute increase in SOFA score of 2 or more points. The quick SOFA (qSOFA) provides bedside screening using three criteria: respiratory rate 22 or greater, altered mental status, and systolic blood pressure 100 mmHg or less. Septic shock is defined as sepsis with persistent hypotension requiring vasopressors to maintain MAP of 65 mmHg or greater and serum lactate greater than 2 mmol/L despite adequate volume resuscitation. Mortality from sepsis ranges from 10-20%, while septic shock carries mortality of 30-50%.

The Hour-1 bundle represents the cornerstone of early sepsis management. Serum lactate should be measured immediately, with repeat measurement within 2-4 hours if the initial level exceeds 2 mmol/L. Blood cultures must be obtained before antibiotic administration, though antibiotics should not be delayed if cultures cannot be obtained promptly. Broad-spectrum intravenous antibiotics targeting the suspected source should be administered within one hour of sepsis recognition. For patients with hypotension or lactate greater than 4 mmol/L, crystalloid fluid resuscitation of at least 30 mL/kg is initiated. Vasopressors are started if hypotension persists despite initial fluid resuscitation to maintain MAP of 65 mmHg.

Source control represents a critical and often underemphasized component of sepsis management. Surgical intervention may be required to drain abscesses, debride necrotic tissue, remove infected foreign bodies, or control hollow viscus perforation. The timing of source control impacts survival, with delays beyond 6-12 hours associated with increased mortality. Common surgical sources include intra-abdominal infections such as perforated appendicitis or diverticulitis, cholangitis requiring biliary drainage, necrotizing fasciitis demanding emergent debridement, and infected vascular grafts. Infected central venous catheters should be removed when identified as the sepsis source. Source control must be weighed against procedural risk, and the least invasive effective intervention should be chosen when multiple options exist.

Ongoing sepsis management involves de-escalation of antibiotics based on culture results, typically within 48-72 hours. Antibiotic duration should be limited to 7-10 days for most infections, with shorter courses appropriate for well-controlled sources. Vasopressors are weaned as tolerated, targeting discontinuation within 24-48 hours of hemodynamic stability. Hydrocortisone at 200 mg per day is considered for patients with septic shock refractory to fluids and vasopressors. Lactate clearance of greater than 10% over 2 hours serves as an indicator of adequate resuscitation. Attention to supportive care includes stress ulcer prophylaxis, venous thromboembolism prevention, glycemic control targeting glucose less than 180 mg/dL, and early mobilization when hemodynamically stable.

<image>Panel A: Sepsis-3 diagnostic criteria flowchart showing progression from suspected infection through SOFA scoring to sepsis and septic shock definitions with mortality rates. Panel B: Hour-1 bundle implementation checklist with timing requirements for lactate, cultures, antibiotics, fluids, and vasopressors. Panel C: Source control examples showing CT images of intra-abdominal abscess amenable to drainage, cholangitis requiring ERCP, and necrotizing fasciitis requiring debridement. Panel D: Sepsis resuscitation monitoring showing lactate clearance trajectory, vasopressor weaning protocol, and de-escalation timeline.</image>

IV. Mechanical Ventilation Fundamentals

Mechanical ventilation provides respiratory support when patients cannot maintain adequate oxygenation or ventilation independently. Indications include hypoxemic respiratory failure with PaO2 less than 60 mmHg despite supplemental oxygen, hypercapnic respiratory failure with pH less than 7.25, airway protection in patients with Glasgow Coma Scale of 8 or less or compromised airway reflexes, and reduction of work of breathing in shock states. Endotracheal intubation using rapid sequence induction remains the standard approach, with video laryngoscopy improving first-pass success rates. Confirmation of proper tube placement includes end-tidal CO2 detection, bilateral breath sounds, and chest radiograph showing the tube tip 3-5 cm above the carina.

Ventilator modes determine how breaths are delivered and supported. Assist-control (AC) ventilation provides full support for every breath, whether patient-triggered or machine-initiated, making it ideal for patients with high work of breathing or hemodynamic instability. Synchronized intermittent mandatory ventilation (SIMV) delivers set mandatory breaths while allowing spontaneous breaths between them, theoretically facilitating weaning. Pressure support ventilation (PSV) augments spontaneous breaths with a set pressure, used for weaning and patients with intact respiratory drive. Pressure-regulated volume control (PRVC) is a hybrid mode that adjusts inspiratory pressure breath-by-breath to achieve a target tidal volume, combining the benefits of pressure-limited and volume-targeted ventilation.

Initial ventilator settings follow evidence-based principles that have dramatically reduced ventilator-induced lung injury. Tidal volume should be set at 6-8 mL/kg of ideal body weight, calculated from patient height rather than actual weight. Respiratory rate is typically 14-18 breaths per minute, adjusted to achieve adequate minute ventilation. FiO2 begins at 100% and is rapidly weaned to maintain SpO2 of 88-95%, targeting less than 60% FiO2 to avoid oxygen toxicity. PEEP starting at 5 cm H2O prevents alveolar collapse and improves oxygenation, with higher levels used in ARDS. Inspiratory flow rates of 40-60 L/min with appropriate I:E ratios allow adequate expiratory time, particularly important in obstructive lung disease.

Ventilator management targets specific physiologic goals while avoiding lung injury. Plateau pressure measured during an inspiratory pause should remain below 30 cm H2O to prevent overdistension. Driving pressure, calculated as plateau pressure minus PEEP, below 15 cm H2O correlates with improved outcomes. Oxygenation targets include PaO2 of 55-80 mmHg or SpO2 of 88-95%, accepting permissive hypoxemia in severe ARDS. pH should be maintained at 7.30-7.45, with permissive hypercapnia acceptable when lung-protective ventilation causes respiratory acidosis. Sedation protocols targeting light sedation (RASS -1 to 0) and daily spontaneous awakening trials reduce ventilator days. Patient-ventilator synchrony assessment identifies dyssynchrony patterns requiring mode or setting adjustments.

<image>Panel A: Endotracheal intubation setup showing video laryngoscope, tube placement confirmation methods (end-tidal CO2 capnography, chest radiograph with proper positioning). Panel B: Ventilator mode comparison showing breath patterns in AC, SIMV, PSV, and PRVC with pressure-time and flow-time waveforms. Panel C: Initial ventilator settings calculator based on ideal body weight with tidal volume, rate, FiO2, and PEEP recommendations. Panel D: Ventilator graphics showing plateau pressure measurement technique, driving pressure calculation, and examples of normal versus abnormal waveforms.</image>

V. Acute Respiratory Distress Syndrome

Acute respiratory distress syndrome (ARDS) is defined by the Berlin criteria as acute-onset respiratory failure within one week of a known clinical insult, with bilateral opacities on chest imaging not fully explained by effusions, collapse, or nodules, and hypoxemia not primarily attributable to cardiac failure. Severity classification uses the PaO2/FiO2 ratio with PEEP of 5 cm H2O or greater: mild ARDS has P/F ratio of 200-300, moderate ARDS has P/F ratio of 100-200, and severe ARDS has P/F ratio less than 100. The pathophysiology involves diffuse alveolar damage with inflammatory cell infiltration, protein-rich pulmonary edema, surfactant dysfunction, and hyaline membrane formation, producing the characteristic decrease in lung compliance and impaired gas exchange.

ARDS results from either direct lung injury or indirect systemic insults. Direct causes include pneumonia (bacterial, viral, or fungal), aspiration of gastric contents, pulmonary contusion from trauma, inhalation injury, and near-drowning. Indirect causes reflect systemic inflammatory responses with secondary lung involvement, including sepsis (the most common cause overall), severe non-thoracic trauma, pancreatitis, massive transfusion, and drug overdose. The common final pathway involves activation of inflammatory cascades, neutrophil recruitment to the lung, endothelial and epithelial barrier disruption, and accumulation of protein-rich edema fluid in the alveolar space. Understanding the underlying etiology guides treatment of the precipitating cause while supporting lung recovery.

Lung-protective ventilation forms the cornerstone of ARDS management and represents one of the few interventions proven to reduce mortality. Low tidal volume ventilation using 6 mL/kg ideal body weight, as established by the ARDSNet trial, reduces ventilator-induced lung injury. Plateau pressure must be maintained below 30 cm H2O, and driving pressure below 15 cm H2O predicts survival. Higher PEEP strategies improve oxygenation and may benefit patients with moderate to severe ARDS by maintaining alveolar recruitment. Conservative fluid management targeting neutral to negative fluid balance reduces pulmonary edema and improves oxygenation without increasing non-pulmonary organ failure. Treatment of the underlying cause remains essential, whether antimicrobial therapy for pneumonia or source control for sepsis.

Adjunctive therapies are considered for patients with severe or refractory ARDS. Prone positioning for at least 16 hours per day improves oxygenation through better ventilation-perfusion matching and reduces mortality in patients with P/F ratio less than 150. Neuromuscular blockade during the first 48 hours may improve outcomes in severe ARDS by eliminating patient-ventilator dyssynchrony and reducing oxygen consumption. Inhaled vasodilators including nitric oxide and epoprostenol improve oxygenation temporarily but have not demonstrated mortality benefit. Venovenous extracorporeal membrane oxygenation (VV-ECMO) serves as rescue therapy for patients with refractory hypoxemia despite optimal ventilator management, providing gas exchange while allowing further lung rest. Recruitment maneuvers using sustained high pressures may open collapsed alveoli but carry risk of hemodynamic compromise and pneumothorax.

<image>Panel A: Berlin criteria for ARDS diagnosis showing chest radiograph examples of bilateral opacities with severity classification by P/F ratio ranges. Panel B: Pathophysiology illustration comparing normal alveolus with ARDS showing inflammatory infiltrates, hyaline membranes, pulmonary edema, and surfactant dysfunction. Panel C: ARDSNet ventilator protocol card showing tidal volume calculation, plateau pressure limits, and PEEP/FiO2 titration tables. Panel D: Prone positioning technique with patient positioning, tube management, and physiologic effects on ventilation-perfusion matching.</image>

VI. Ventilator Weaning and Liberation

Assessment for extubation readiness begins with evaluation of clinical criteria that predict successful weaning. The underlying cause of respiratory failure should be improving or resolved. Oxygenation requirements should be minimal, with FiO2 of 40% or less and PEEP of 5-8 cm H2O or less. Patients should be hemodynamically stable without significant vasopressor requirements. Neurologically, patients must be awake enough to follow commands and protect their airway. Adequate cough strength is necessary to clear secretions, and secretion volume should be manageable. Acid-base status should be stable, and any metabolic derangements corrected. Patients who meet these criteria proceed to spontaneous breathing trial assessment.

The spontaneous breathing trial (SBT) represents the key diagnostic test for extubation readiness. Three methods are commonly used: T-piece trials where the patient breathes through the endotracheal tube without ventilator support, continuous positive airway pressure (CPAP) at 5 cm H2O, or low-level pressure support ventilation at 5-8 cm H2O. The trial duration typically ranges from 30 to 120 minutes. Failure criteria include tachypnea greater than 35 breaths per minute, hypoxemia with SpO2 less than 88%, significant tachycardia or hypertension, diaphoresis, use of accessory muscles, or patient distress. Rapid shallow breathing index (respiratory rate divided by tidal volume in liters) greater than 105 predicts weaning failure. Patients passing the SBT have high probability of successful extubation.

Extubation requires assessment beyond the spontaneous breathing trial. Cuff leak test, performed by deflating the endotracheal tube cuff and assessing air leak around the tube, helps identify patients at risk for post-extubation stridor from laryngeal edema. Absence of cuff leak suggests potential airway compromise, and prophylactic corticosteroids may be administered before extubation. The ability to follow commands and protect the airway from aspiration is essential. Secretion management should be adequate without requiring suctioning more frequently than every 2 hours. After extubation, patients are monitored closely for signs of respiratory distress. High-flow nasal cannula or non-invasive ventilation may be used prophylactically in high-risk patients to prevent reintubation.

Weaning failure occurs in 10-20% of patients and requires systematic evaluation. Respiratory causes include residual lung pathology, diaphragmatic weakness, or excessive secretions. Cardiac causes include fluid overload precipitating pulmonary edema when positive pressure ventilation is removed. Neurologic causes include sedation effects, delirium, or critical illness polyneuropathy. Metabolic factors such as electrolyte abnormalities, anemia, or malnutrition contribute to respiratory muscle weakness. Management involves addressing identified causes: diuresis for volume overload, nutrition optimization, correction of electrolyte abnormalities, and rehabilitation for weakness. Patients requiring prolonged mechanical ventilation may benefit from tracheostomy, typically considered after 10-14 days of intubation when continued ventilator support is anticipated.

<image>Panel A: Extubation readiness checklist showing clinical criteria for oxygenation, hemodynamics, neurologic status, and secretion management thresholds. Panel B: Spontaneous breathing trial setup comparing T-piece, CPAP, and pressure support methods with pass/fail criteria displayed. Panel C: Cuff leak test technique showing tube cuff deflation and assessment for air leak around the tube with laryngeal edema illustration. Panel D: Algorithm for weaning failure evaluation showing respiratory, cardiac, neurologic, and metabolic causes with corresponding interventions.</image>

VII. Nutrition in Critical Illness

The metabolic response to critical illness follows distinct phases that influence nutritional requirements. The ebb phase occurs immediately after injury, lasting 12-24 hours, characterized by decreased metabolic rate and peripheral vasoconstriction as the body prioritizes vital organ perfusion. The flow phase begins at days 2-3, marked by hypermetabolism, protein catabolism, and altered substrate utilization. Critically ill patients may require 25-30 kcal/kg/day during the hypermetabolic phase. Hyperglycemia results from insulin resistance, increased gluconeogenesis, and counterregulatory hormone release, requiring glucose monitoring and insulin therapy to maintain levels below 180 mg/dL. The anabolic recovery phase begins with resolution of inflammation and is supported by adequate protein and caloric intake.

Nutritional assessment in critical illness differs from outpatient evaluation because acute inflammation confounds traditional markers. Serum albumin reflects inflammatory status rather than nutritional state, with levels dropping rapidly during acute illness regardless of nutritional status. Prealbumin has a shorter half-life and may be more responsive to acute changes but is still affected by inflammation. Clinical assessment integrating history of recent weight loss, pre-existing nutritional deficits, and severity of illness provides the most useful information. Indirect calorimetry measuring oxygen consumption and carbon dioxide production allows precise determination of energy expenditure in individual patients. In the absence of indirect calorimetry, predictive equations using weight, height, and illness severity estimate caloric needs, though these may over- or underestimate actual requirements.

Enteral nutrition is the preferred route of nutrient delivery in critically ill patients with a functional gastrointestinal tract. Early enteral feeding within 24-48 hours of ICU admission maintains gut barrier integrity, reduces bacterial translocation, modulates the immune response, and is associated with reduced infectious complications. Gastric feeding through nasogastric or orogastric tubes is appropriate for most patients. Post-pyloric feeding through nasojejunal or surgically placed jejunostomy tubes may benefit patients with delayed gastric emptying or high aspiration risk. Initiation involves starting at 10-20 mL/hour with advancement to goal over 24-72 hours, targeting 80% of estimated needs by day 3. Gastric residual volume monitoring, while common, does not reliably predict aspiration, and feeds should not be held for residuals less than 500 mL without other signs of intolerance.

Parenteral nutrition is reserved for patients who cannot receive adequate enteral nutrition. Indications include complete bowel obstruction, short bowel syndrome with insufficient absorptive capacity, severe ileus unresponsive to promotility agents, and high-output gastrointestinal fistulae. When enteral nutrition is not possible, parenteral nutrition should be initiated by day 5-7 in patients who were previously well-nourished and earlier in malnourished patients. Parenteral solutions contain dextrose, amino acids, and lipid emulsion, along with electrolytes, vitamins, and trace elements. Complications include catheter-related bloodstream infections, hyperglycemia, hepatic steatosis, and refeeding syndrome in malnourished patients. Supplemental parenteral nutrition combined with suboptimal enteral nutrition may be considered when enteral delivery remains inadequate after the first week.

<image>Panel A: Timeline of metabolic phases in critical illness (ebb, flow, anabolic) with corresponding changes in metabolic rate, protein catabolism, and insulin resistance. Panel B: Enteral access options showing nasogastric tube placement, post-pyloric tube positioning, and surgical feeding tube options (gastrostomy, jejunostomy). Panel C: Enteral nutrition advancement protocol with starting rates, advancement schedules, and intolerance management. Panel D: Parenteral nutrition composition diagram showing macronutrient components, micronutrient additions, and common complications with prevention strategies.</image>

VIII. Common ICU Complications and Prevention

Ventilator-associated pneumonia (VAP) represents the most common nosocomial infection in mechanically ventilated patients, occurring in 10-25% of patients ventilated for more than 48 hours. Pathogenesis involves aspiration of oropharyngeal secretions colonized with pathogenic bacteria around the endotracheal tube cuff. Diagnosis requires clinical suspicion based on new or worsening infiltrate, fever, leukocytosis, and purulent secretions, combined with microbiologic confirmation from endotracheal aspirate or bronchoalveolar lavage cultures. Common pathogens include Pseudomonas aeruginosa, Staphylococcus aureus, and gram-negative enterics. Treatment involves empiric broad-spectrum antibiotics based on local antibiogram, with de-escalation guided by culture results and clinical response. Duration of therapy is typically 7-8 days for uncomplicated VAP.

Prevention of VAP employs bundled interventions targeting multiple risk factors. Elevation of the head of bed to 30-45 degrees reduces aspiration of gastric contents. Twice-daily oral care with chlorhexidine reduces oropharyngeal bacterial colonization. Subglottic secretion drainage using specialized endotracheal tubes removes pooled secretions above the cuff. Minimizing sedation depth and daily spontaneous awakening trials reduce ventilator duration. Peptic ulcer prophylaxis, while protecting against gastrointestinal bleeding, may increase pneumonia risk through altered gastric pH; therefore, benefits must be weighed against risks. Ventilator circuit changes should occur only when visibly soiled rather than on routine schedules. The most effective VAP prevention strategy is minimizing duration of mechanical ventilation.

Central line-associated bloodstream infection (CLABSI) carries significant morbidity and mortality and is largely preventable through standardized insertion and maintenance practices. The insertion bundle includes hand hygiene, maximum sterile barrier precautions with cap, mask, sterile gown, sterile gloves, and large sterile drape, chlorhexidine skin antisepsis with 2 minutes of drying time, avoidance of femoral insertion when possible, and prompt removal of unnecessary catheters. Maintenance practices include daily assessment of catheter necessity with removal when no longer needed, proper hand hygiene before accessing the line, scrubbing access ports with antiseptic before each use, and optimal catheter site care with chlorhexidine-impregnated dressings. When CLABSI is suspected, blood cultures should be drawn from the catheter and peripherally, and the catheter should be removed if not essential.

Venous thromboembolism prophylaxis is mandatory for virtually all ICU patients given their high risk status. Risk factors in critically ill patients include immobility, central venous catheters, mechanical ventilation, vasopressor use, sepsis, and underlying comorbidities. Pharmacologic prophylaxis with low-molecular-weight heparin or unfractionated heparin is preferred when not contraindicated by active bleeding or severe thrombocytopenia. Mechanical prophylaxis with intermittent pneumatic compression devices is used in patients with contraindications to anticoagulation or in combination with pharmacologic prophylaxis for highest-risk patients. Stress ulcer prophylaxis with proton pump inhibitors or H2 receptor blockers is indicated for patients with risk factors including mechanical ventilation for more than 48 hours, coagulopathy, or history of gastrointestinal bleeding, balanced against potential risks of Clostridium difficile infection and pneumonia.

<image>Panel A: VAP pathogenesis illustration showing oropharyngeal colonization, microaspiration around endotracheal tube cuff, and development of pneumonia with typical chest radiograph findings. Panel B: VAP prevention bundle checklist with head of bed elevation, oral care, sedation vacation, and ventilator weaning protocol components. Panel C: CLABSI prevention insertion bundle showing maximum barrier precautions, chlorhexidine skin preparation, ultrasound-guided placement, and proper draping technique. Panel D: VTE and stress ulcer prophylaxis decision algorithm based on bleeding risk, thrombosis risk, and patient-specific factors.</image>

IX. Acute Kidney Injury in the ICU

Acute kidney injury (AKI) in critically ill patients is classified using the Kidney Disease: Improving Global Outcomes (KDIGO) staging system. Stage 1 AKI is defined as serum creatinine increase of 0.3 mg/dL or more within 48 hours, or creatinine 1.5-1.9 times baseline, or urine output less than 0.5 mL/kg/hour for 6-12 hours. Stage 2 includes creatinine 2.0-2.9 times baseline or urine output less than 0.5 mL/kg/hour for 12 or more hours. Stage 3 encompasses creatinine 3.0 times baseline or increase to 4.0 mg/dL or more, urine output less than 0.3 mL/kg/hour for 24 or more hours, anuria for 12 or more hours, or initiation of renal replacement therapy. AKI occurs in up to 50% of ICU patients and is independently associated with increased mortality.

The etiology of AKI in the ICU setting differs from outpatient populations. Pre-renal causes from inadequate renal perfusion predominate initially, resulting from hypovolemia, cardiogenic shock, or severe vasodilation in sepsis. Intrinsic renal injury, particularly acute tubular necrosis (ATN), develops from prolonged ischemia or nephrotoxic exposure. Common nephrotoxins include intravenous contrast agents, aminoglycoside antibiotics, vancomycin, amphotericin, and nonsteroidal anti-inflammatory drugs. Rhabdomyolysis from crush injury or prolonged immobilization causes myoglobin-induced tubular injury. Abdominal compartment syndrome impairs renal blood flow through elevated intra-abdominal pressure. Post-renal obstruction, while less common in ICU patients, should be excluded with ultrasound when AKI develops.

Prevention strategies focus on optimizing renal perfusion and avoiding nephrotoxic insults. Maintaining adequate mean arterial pressure through fluid resuscitation and vasopressors supports renal blood flow. Avoiding nephrotoxic medications when possible, or using alternatives and adjusting doses for renal function, reduces drug-induced injury. When contrast administration is necessary, preprocedural hydration with isotonic crystalloid and use of iso-osmolar contrast agents minimize contrast-induced nephropathy risk. Volume overload paradoxically worsens AKI by causing venous congestion that increases renal interstitial pressure and impairs perfusion. Diuretics may be used to manage volume overload but do not prevent or treat AKI and should not delay initiation of renal replacement therapy when indicated.

Renal replacement therapy (RRT) is indicated for life-threatening complications of AKI refractory to medical management. Absolute indications include refractory hyperkalemia greater than 6.5 mEq/L with ECG changes, severe metabolic acidosis with pH less than 7.1 unresponsive to bicarbonate therapy, volume overload with pulmonary edema not responding to diuretics, and uremic complications including encephalopathy, pericarditis, or bleeding. Modality selection includes continuous renal replacement therapy (CRRT) preferred for hemodynamically unstable patients due to slower fluid and solute removal, while intermittent hemodialysis (IHD) is appropriate for stable patients. CRRT modalities include continuous venovenous hemofiltration (CVVH), hemodialysis (CVVHD), or hemodiafiltration (CVVHDF). Anticoagulation of the circuit, typically with citrate or heparin, prevents clotting and optimizes filter life.

<image>Panel A: KDIGO AKI staging criteria table showing creatinine and urine output thresholds for stages 1, 2, and 3 with corresponding outcomes data. Panel B: AKI etiology diagram categorizing pre-renal, intrinsic, and post-renal causes with specific examples relevant to ICU patients. Panel C: Nephrotoxin avoidance strategies showing common ICU medications requiring dose adjustment or alternatives, contrast protocols, and monitoring recommendations. Panel D: Renal replacement therapy comparison showing CRRT circuit diagram with continuous slow solute removal versus intermittent hemodialysis with indications for each modality.</image>

X. End-of-Life Care in the Surgical ICU

Goals of care discussions represent essential communication between the medical team and patients or their surrogate decision-makers. These conversations should occur early in the ICU course rather than only when death is imminent. The discussion framework includes providing clear, honest prognostic information about the likely outcomes with and without continued aggressive treatment. Understanding patient values involves exploring what quality of life the patient would consider acceptable and what they would want if recovery to baseline function were unlikely. Surrogate decision-makers must be identified according to legal hierarchy if the patient lacks decision-making capacity. All discussions and decisions should be documented clearly in the medical record, with regular updates as the clinical situation evolves.

Palliative care focuses on symptom management and quality of life when curative treatment is no longer appropriate or desired. Pain management uses opioids titrated to comfort, with morphine and hydromorphone being common choices. Dyspnea responds to opioids, positioning, and supplemental oxygen even when hypoxemia is not present, through reduction of the subjective sensation of breathlessness. Anxiety and agitation are managed with benzodiazepines such as lorazepam or midazolam. Excessive respiratory secretions causing distressing noise ("death rattle") respond to glycopyrrolate or scopolamine. Palliative care consultation provides expertise in symptom management and communication support for difficult conversations. The focus shifts from disease treatment to patient comfort, honoring the individual's preferences and dignity.

Withdrawal of life-sustaining treatment is ethically appropriate when continued intervention is inconsistent with patient wishes or provides no meaningful benefit. This decision ideally involves consensus among the medical team and family, guided by the patient's previously expressed wishes or substituted judgment. Before withdrawal, adequate analgesia and sedation should be provided to ensure patient comfort during the dying process. Extubation may be performed after ensuring comfort measures are in place, or in some cases patients are transitioned to comfort-focused ventilator settings if extubation is not desired by the family. The patient and family should be prepared for what to expect, including the timeline and physical changes that may occur. Family members should be allowed to be present during withdrawal if they wish.

Organ donation represents an important consideration in end-of-life care that can provide meaning for families and benefit recipients in need. Legal requirements mandate notification of the organ procurement organization (OPO) when death is imminent or brain death is suspected. The OPO coordinates evaluation of donation potential and approaches the family regarding consent. Brain death declaration follows established protocols including clinical examination and ancillary testing when required. Donation after circulatory death (DCD) provides an alternative pathway when brain death criteria are not met. The medical team should not participate in requesting donation; this conversation is conducted by trained OPO personnel. Donor management involves maintaining physiologic stability to optimize organ function until procurement. Few absolute contraindications to donation exist, and the OPO should be contacted for all potential donors.

<image>Panel A: Goals of care discussion framework showing communication structure with prognostic information delivery, values exploration, and decision-making support with documentation requirements. Panel B: Palliative symptom management chart showing medication protocols for pain, dyspnea, anxiety, and secretions with dosing guidelines. Panel C: Withdrawal of life support process flowchart including family meeting, comfort orders, extubation procedure, and expected timeline. Panel D: Organ donation process overview showing OPO notification triggers, brain death evaluation, DCD protocol, and donor management principles.</image>

Summary

• Shock classification distinguishes hypovolemic (decreased CO, increased SVR), cardiogenic (decreased CO, increased SVR, elevated filling pressures), distributive (increased CO, decreased SVR), and obstructive (mechanical impediment) types
• Sepsis-3 defines sepsis as infection causing organ dysfunction (SOFA increase of 2 or more); septic shock requires vasopressors despite fluids with lactate greater than 2 mmol/L
• Hour-1 sepsis bundle includes lactate measurement, blood cultures, broad-spectrum antibiotics, crystalloid fluids (30 mL/kg), and vasopressors for persistent hypotension
• Source control within 6-12 hours is critical for sepsis survival and may require surgical drainage, debridement, or device removal
• Lung-protective ventilation uses tidal volumes of 6-8 mL/kg ideal body weight with plateau pressure less than 30 cm H2O and driving pressure less than 15 cm H2O
• ARDS severity is classified by P/F ratio: mild (200-300), moderate (100-200), severe (less than 100); prone positioning improves mortality when P/F is less than 150
• Weaning assessment includes SBT with criteria of FiO2 40% or less, PEEP 5-8 cm H2O or less, hemodynamic stability, and adequate mental status
• Enteral nutrition is preferred and should start within 24-48 hours; parenteral nutrition is reserved for GI tract failure
• VAP and CLABSI prevention require bundled interventions including oral care, head of bed elevation, maximum barrier precautions, and daily necessity review
• AKI staging uses KDIGO criteria; RRT is indicated for refractory hyperkalemia, acidosis, volume overload, or uremic complications
• End-of-life care includes goals discussions, palliative symptom management, ethical withdrawal of support, and organ donation consideration

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown